Keywords: |
adult; clinical article; aged; united states; cancer patient; rituximab; nuclear magnetic resonance imaging; follow up; magnetic resonance imaging; t lymphocyte; t-lymphocytes; immunoglobulin; acute lymphoblastic leukemia; cancer regression; nonhodgkin lymphoma; brain; cognitive defect; mirtazapine; progressive multifocal leukoencephalopathy; leukoencephalopathy, progressive multifocal; motor dysfunction; cerebrospinal fluid analysis; brain biopsy; cd19 antigen; mefloquine; humans; human; male; female; article; pembrolizumab; tisagenlecleucel t; chimeric antigen receptor t-cell immunotherapy; axicabtagene ciloleucel; receptors, chimeric antigen
|